Garden State Investment Advisory Services LLC Gilead Sciences, Inc. Transaction History
Garden State Investment Advisory Services LLC
- $336 Billion
- Q4 2024
A detailed history of Garden State Investment Advisory Services LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Garden State Investment Advisory Services LLC holds 2,671 shares of GILD stock, worth $299,285. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,671
Previous 2,633
1.44%
Holding current value
$299,285
Previous $221 Million
11.8%
% of portfolio
0.07%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,107Shares Held
989MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.03 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.77 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.49 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $140B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...